88 results
8-K
EX-99.1
BPMC
Blueprint Medicines Corp
6 May 20
Blueprint Medicines Reports First Quarter 2020 Financial Results
7:14am
business,” said Jeff Albers, Chief Executive Officer of Blueprint Medicines. “Despite challenges related to the COVID-19 pandemic and top-line results from … and PATHFINDER trials of avapritinib in advanced SM in the third quarter of 2020.
Response to the COVID-19 Pandemic and Potential Business Impacts
Due
8-K
EX-99.2
6r37dtpeaqgsc4ko2
1 Apr 20
Regulation FD Disclosure
8:12am
8-K
EX-99.1
jajrlljzfbmw6lf7edi
9 Nov 21
Blueprint Medicines and Zai Lab Announce Strategic Collaboration and License Agreement for BLU-945 and BLU-701 in Greater China
8:39am
8-K
EX-99.1
1zj939wq aqav89
15 May 20
Blueprint Medicines Receives Complete Response Letter from FDA for Avapritinib
8:30am
8-K
EX-99.1
6o5rw0dvzgbqfjtm6
30 Dec 21
Blueprint Medicines Completes Acquisition of Lengo Therapeutics
9:11am
8-K
EX-99.1
pgn39qdb3ddv86x
23 Jun 22
Blueprint Medicines Appoints Habib Dable to its Board of Directors
4:33pm
8-K
EX-99.1
9rlvb1r yh7dltet4kf4
10 Dec 21
Blueprint Medicines Appoints Daniella Beckman to its Board of Directors
12:00am